Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study

BACKGROUND: Spontaneous pneumothorax has a high incidence and high rate of recurrence in patients with lymphangioleiomyomatosis (LAM). The risk factors for pneumothorax and the effects of sirolimus on pneumothorax in patients with LAM are unknown. In our study, multivariate logistic regression was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chongsheng, Xu, Wenshuai, Wang, Yani, Zhang, Tengyue, Yang, Luning, Zhou, Wangji, Hu, Danjing, Yang, Yanli, Tian, Xinlun, Xu, Kai-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264575/
https://www.ncbi.nlm.nih.gov/pubmed/35804431
http://dx.doi.org/10.1186/s13023-022-02418-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264575/
https://www.ncbi.nlm.nih.gov/pubmed/35804431
http://dx.doi.org/10.1186/s13023-022-02418-2

Ejemplares similares